Rhythm Pharmaceuticals buy Morgan Stanley
Start price
11.12.25
/
50%
€100.00
Target price
11.12.26
-
Performance (%)
-3.50%
Price
12.12.25
€98.50
Summary
This prediction is currently active. With a performance of -3.50%, the BUY prediction for Rhythm Pharmaceuticals by Morgan_Stanley is down slightly. This prediction currently runs until 11.12.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | -3.50% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€95.00
16.10.25
16.10.25
€110.50
16.10.26
16.10.26
1.58%
12.12.25
12.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
18.67%
12.12.25
12.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
29.53%
12.12.25
12.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
106.20%
12.12.25
12.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24

